'Substantial variation' in stocks of essential antidotes at UK hospitals

August 8, 2012

There is "substantial variation" in the stocks of essential antidotes used to treat various types of life threatening poisoning incidents in UK acute hospitals, finds research published online in Emergency Medicine Journal.

National guidance produced jointly by the National Poisons Information Service and the College of Emergency Medicine in 2008 recommends the stocking of 29 at every with an emergency care department or inpatient beds for treating serious cases of .

Eleven of the antidotes are recommended for immediate availability (category A); 13 within an hour (category B); while 4 are classed as category C, meaning that they need to be available at designated regional centres.

These antidotes are intended to cover a range of cases, including toxic alcohol poisoning, and .

The authors surveyed all 224 acute hospitals in England, Wales, and Scotland about their stocks of all categories of antidotes. In all, 196 hospitals (87.5%) responded: 141 in England; 21 in Wales; and 34 in Scotland.

They also asked about the availability of Intralipid, which has come into clinical use since the 2008 guidelines, and which is used to counter the effects of patients severely poisoned by local anaesthetics and other fat soluble drugs.

The responses showed that most hospitals (90%) stocked commonly used category A antidotes, such as acetylcysteine (paracetamol overdose), activated charcoal (a range of swallowed toxins), (illicit drug overdose) and flumazenil (sleeping pill/tranquillizer overdose).

But the availability of cyanide poisoning antidotes was much lower, ranging from one out of five (21%) for hydroxocobalamin to three out of four (74%) for dicobalt edetate.

Dicobalt edetate is the preferred treatment for severe cyanide poisoning, but was not available in 29 (15%) hospitals. Nine of these hospitals held no other antidote for cyanide poisoning cases.

Altogether only half (100 out of 196) of all hospitals held all the other seven category A antidotes.

Intralipid was available in 62% of hospitals, despite not being included in the 2008 guidelines.

Out of the category B list, most (90%+) hospitals carried dantrolene (muscle relaxant), desferrioxamine (for iron overload), and phytomenadione (synthetic vitamin K to treat excessive bleeding), but less than half (47%) stocked cyproheptadine or the viper venom antiserum.

And the availability of antidotes for toxic alcohol and glycol poisoning was also less than optimal, the survey responses showed, with levels of availability for the three recommended antidotes ranging from 17% to 72%.

Excluding the acute toxic antidotes, less than one in 10 hospitals stocked all the other 10 recommended antidotes.

The antidotes held at regional centres are those that are likely to be used only rarely. Nevertheless, availability ranged from 4% (mercury poisoning) to 25% (lead poisoning).

And it is unclear why only one in three hospitals designated to hold stocks of pralidoxime (by the Department of Health), used to treat insecticide poisoning, actually did so, say the authors.

"While antidotes that are used commonly are widely available, those needed to treat less commonly encountered poisonings are often not stocked," they write.

"This is of concern, because poisoning with the agents concerned [ digoxin, cyanide, and toxic alcohols] is frequently associated with severed morbidity and mortality, and the timely use of an antidote may be life saving."

The authors say that despite the publication of the 2008 guidelines, the picture has improved little since 2007. Limited awareness, lack of availability and high cost may all be contributory factors, they suggest.

Explore further: University of Minnesota and start-up to develop antidote to cyanide poisoning

Related Stories

University of Minnesota and start-up to develop antidote to cyanide poisoning

February 9, 2012
Cyanide poisoning is often fatal and typically affects victims of industrial accidents, terrorist attacks, or structural fires. Based on research conducted at the Center for Drug Design at the University of Minnesota, startup ...

Fall in deaths involving painkiller co-proxamol after drug withdrawn in UK

May 8, 2012
During the six years following the withdrawal of the analgesic co-proxamol in the UK in 2005, there was a major reduction in poisoning deaths involving this drug, without apparent significant increase in deaths involving ...

Recommended for you

Exploring the potential of human echolocation

June 25, 2017
People who are visually impaired will often use a cane to feel out their surroundings. With training and practice, people can learn to use the pitch, loudness and timbre of echoes from the cane or other sounds to navigate ...

Team eradicates hepatitis C in 10 patients following lifesaving transplants from infected donors

April 30, 2017
Ten patients at Penn Medicine have been cured of the Hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease. The findings point to new strategies for increasing ...

'bench to bedside to bench': Scientists call for closer basic-clinical collaborations

March 24, 2017
In the era of genome sequencing, it's time to update the old "bench-to-bedside" shorthand for how basic research discoveries inform clinical practice, researchers from The Jackson Laboratory (JAX), National Human Genome Research ...

The ethics of tracking athletes' biometric data

January 18, 2017
(Medical Xpress)—Whether it is a FitBit or a heart rate monitor, biometric technologies have become household devices. Professional sports leagues use some of the most technologically advanced biodata tracking systems to ...

Financial ties between researchers and drug industry linked to positive trial results

January 18, 2017
Financial ties between researchers and companies that make the drugs they are studying are independently associated with positive trial results, suggesting bias in the evidence base, concludes a study published by The BMJ ...

Best of Last Year – The top Medical Xpress articles of 2016

December 23, 2016
(Medical Xpress)—It was a big year for research involving overall health issues, starting with a team led by researchers at the UNC School of Medicine and the National Institutes of Health who unearthed more evidence that ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.